Skip to main content

Table 2 Pooled analysis of AEs (sorted by descending order) extracted from the studies that directly compared doxofyline with theophylline in asthmatic patients

From: Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis

 

Doxofylline

Theophylline

Total number of asthmatic patients

228

220

 

%

n

%

n

Asthmatic patients reporting at least one AE

46.05

105

57.73

127

Total number of AEs

 headache

20.61

47

23.64

52

 nausea

10.96

25

21.82

48

 nervousness

4.39

10

11.36

25

 insomnia

6.14

14

9.55

21

 dyspepsia

6.58

15

8.18

18

 vomiting

3.51

8

4.09

9

 dizziness

3.95

9

3.18

7

 cough increased

0.44

1

3.64

8

 overdose

0.00

0

3.64

8

 rhinitis

3.51

8

2.73

6

 diarrhoea

3.07

7

3.18

7

 asthma

3.07

7

3.18

7

 abdominal pain

2.63

6

1.82

4

 pharyngitis

1.32

3

2.27

5

 palpitations

2.19

5

1.82

4

 chest pain

2.19

5

0.00

0

 epigastric distress

0.88

2

1.82

4

 asthenia

0.00

0

1.82

4

 tremors

0.00

0

0.91

2

 somnolence

0.44

1

0.45

1

 sore throat

0.00

0

0.45

1

  1. AE adverse event